Loading Page
Dr. Lloyd McPherson Felmly, MD is a general surgeon in Charleston, SC specializing in general surgery, pediatric transplant surgery and pediatric cardiothoracic surgery. He graduated from Medical University of South Carolina in 2015 and has 11 years of experience. Dr. Lloyd McPherson Felmly, MD is affiliated with MUSC Health, MUSC Children's Health Surgery at Shawn Jenkins Children's Hospital and UNIVERSITY MEDICAL ASSOCIATES OF THE MEDICAL UNIVERSITY OF SOUTH CAROL.
Lung Transplant
Patients who have very severe lung disease may need a lung transplant. The diseased lung is entirely removed and replaced with a healthy lung, usually donated by a person who died. Either one or both lungs can be transplanted.
Contrary to popular belief, lung transplant is rarely used to treat lung cancer. It is a more common treatment for patients with other advanced lung diseases, such as cystic fibrosis, sarcoidosis, pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD). Lung transplant is a serious operation and is generally used as a last resort for patients who have only a short time to live without surgery.
During a transplant, an incision is made on the side of the chest (for a single lung) or in the middle (for both lungs). Patients may be hooked up to a heart-lung bypass machine, which will do the work of moving blood and oxygen through the body during the procedure. After the diseased lung is cut away from the main airway and blood vessels, the donor lung is stitched into place. Surgery may take as long as twelve hours, and a hospital stay of two to three weeks after surgery is not uncommon. For the first hours or day after surgery, patients use a ventilator, or a machine to help them breathe. Tubes will be inserted into the chest to help drain excess air and fluid. During recovery, physical therapy and breathing exercises are used to help the new lung work as well as possible.
Lung capacity is carefully monitored for several months after surgery. Patients who have had a transplant will also have to take anti-rejection drugs for the rest of their lives. These drugs stop the body's immune system from attacking the new lung. The main risks after a transplant are infection and rejection (when the immune system attacks the 'foreign' lung). A healthy lifestyle, including maintaining a diet high in vegetables and lean protein, not smoking, and getting enough exercise, is important to keeping the lungs functioning as well as possible. With proper care, many patients can live ten or even twenty years after a lung transplant.
Dr. Lloyd McPherson Felmly, MD graduated from Medical University of South Carolina in 2015. He completed residency at Medical University of South Carolina. He has a state license in South Carolina.
Medical School: Medical University of South Carolina (2015)
Residency: Medical University of South Carolina (2021)
Licensed In: South Carolina
Dr. Lloyd McPherson Felmly, MD appears to accept the following insurance providers: Medcost, Aetna Medicare, Cigna Medicare, WellCare, Blue Cross Blue Shield Blue Choice HealthCare (Group Health Plan), Blue Choice Blue Option (Marketplace), United HealthCare, Great West Healthcare (Part of Cigna now), Absolute Total Care Healthy Connections Prime Dual Medicare/Medicaid Plan , Humana Healthy Horizons (through March 31, 2025), Cigna, Veterans' Affairs Community Care Network (CCN), Molina Healthy Connections Prime Dual Medicare/Medicaid Plan, Tricare, Coventry, Employers Health Network (EHN), First Health, BCBS Blue Essentials (Marketplace), AllWell by Absolute Total Care, Aetna (Open Choice), First Choice Next, Ambetter from Absolute Total Care (Marketplace) , Blue Cross Blue Shield Planned Administrators, Aetna (Exclusive Choice), First Choice/Select Health (NEIC), Blue Cross Blue Shield State Health Plan for South Carolina, Aetna (Managed Choice), Aetna (Preferred Provider Organization), Blue Cross Blue Shield Federal (FEP), Blue Cross Blue Shield Preferred Blue (PPC), Absolute Total Care (NEIC), Medicare A & B (Traditional Medicare), Clover Health , Blue Cross Blue Shield Medicare, Clover Health, Ambetter from Absolute Total Care (Marketplace) and BCBS Blue Essentials (Marketplace).
According to our sources, Dr. Lloyd McPherson Felmly, MD accepts the following insurance providers:
Dr. Lloyd McPherson Felmly, MD does not have any reviews yet, be the first to leave a review of Dr. Lloyd McPherson Felmly, MD here: Leave a Review
These charts describe general payments received by Dr. Lloyd McPherson Felmly, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$849
Impella $137 |
$712 |
|||||
|
$739
ATRICLIP LAA EXCLUSION SYSTEM $321 |
ATRICURE SYNERGY ABLATION SYSTEM $300 |
AtriCure cryoICE cryoSPHERE Cryoablation System $92 |
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $27 |
|||
|
$649
SynerGraft $447 |
PhotoFix $202 |
|||||
|
$471
PancreasPak $237 |
$234 |
|||||
|
$441
FLOSEAL $303 |
PREVELEAK $138 |
|||||
|
$1,842
SternaLock Blu $314 |
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $186 |
HEMOBLAST Bellows $171 |
Da Vinci Surgical System $141 |
MATRIXRIB $125 |
Other $906 |
| $4,769 | |
| $223 |
Dr. Lloyd M. Felmly is a pediatric cardiac surgeon specializing in repairing congenital heart defects. He was born in New York City, NY, and grew up in Columbia, SC. He graduated from medical school at the Medical University of South Carolina (MUSC) in 2015. He then completed post-graduate training in cardiothoracic surgery, also at MUSC. Following this, he completed two years of pediatric cardiac surgery subspecialty fellowship at Stanford University under Dr. Frank Hanley. There he learned to care for some of the most complicated congenital defects in the world and developed a strong interest in pulmonary artery reconstruction and complex biventricular repair. Dr. Felmly's clinical interests include neonatal and infant heart surgery, with an emphasis on Tetralogy of Fallot and pulmonary atresia. He specializes in procedures to create new pulmonary arteries in patients with major aortopulmonary collaterals (MAPCAs) and to relieve blockages in pulmonary arteries due to peripheral pulmonary stenoses (PPAS). He also has significant experience in aortic and mitral valve repair, heart and lung transplantation, the treatment of anomalous coronary arteries, and double switch operations for patients with congenitally corrected transposition of the great arteries (CCTGA), and other disorders such as heterotaxy. Dr. Felmly is a member of the Society of Thoracic Surgeons and has given numerous presentations at national and regional meetings. Additionally, he has authored many peer-reviewed journal articles and book chapters. His research interests include studying the clinical outcomes of patients undergoing operations for complex pulmonary artery abnormalities.
